methylprednisolone 125 MG Injection
- RxCUI
- 1743704
- RxNorm name
- methylprednisolone 125 MG Injection
- Display name
- methylPREDNISolone (Injectable)
- Full name
- methylprednisolone 125 MG Injection
- Term type
- SCD
- Status
- Active
- Strength
- 125 mg
- Dose form
- Injection
- Route
- Injectable
- Updated
- 2026-10-24 12:28:06
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042016
- Active start
- 042016
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| methylprednisolone sodium succinate | 125 MG / 1 EACH | methylprednisolone | methylprednisolone |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| methylprednisolone | 6902 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | methylPREDNISolone 125 MG Injection | 1 | NAMES |
| RxNorm Name | methylprednisolone 125 MG Injection | 1 | NAMES |
| RxNorm Synonym | methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 11 linked values
| 11 | CODES |
| RxCUI | 1743704 | 1 | CODES |
| MMSL_CODE | 3 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0143-9754-25 | 0143-9754 | Methylprednisolone Sodium Succinate Methylprednisolone Sodium Succinate | Hikma Pharmaceuticals USA Inc. | ANDA203125 |
| 43598-129-25 | 43598-129 | Methylprednisolone sodium succinate Methylprednisolone sodium succinate | Dr. Reddy's Laboratories Inc | ANDA212396 |
| 51662-1263-3 | 51662-1263 | SOLU-MEDROL SOLU-MEDROL | HF Acquisition Co. LLC, DBA HealthFirst | NDA011856 |
| 55150-263-03 | 55150-263 | Methylprednisolone Sodium Succinate Methylprednisolone Sodium Succinate | Eugia US LLC | ANDA207667 |
| 63323-258-03 | 63323-258 | Methylprednisolone Sodium Succinate METHYLPREDNISOLONE SODIUM SUCCINATE | Fresenius Kabi USA, LLC | ANDA040583 |
| 70121-1001-5 | 70121-1001 | Methylprednisolone Sodium Succinate Methylprednisolone | Amneal Pharmaceuticals LLC | ANDA207549 |
| 70518-3684-0 | 70518-3684 | Methylprednisolone sodium succinate Methylprednisolone sodium succinate | REMEDYREPACK INC. | ANDA212396 |
| 70518-4345-0 | 70518-4345 | Methylprednisolone Sodium Succinate Methylprednisolone Sodium Succinate | REMEDYREPACK INC. | ANDA203125 |
| 72572-098-25 | 72572-098 | Methylprednisolone Sodium Succinate Methylprednisolone Sodium Succinate | Civica, Inc. | ANDA203125 |
| 82094-402-50 | 82094-402 | Methylprednisolone Sodium Succinate Methylprednisolone | Tianjin Kingyork Pharmaceuticals Co., Ltd | ANDA212396 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA203125 | 0143-9754 | Methylprednisolone Sodium Succinate Methylprednisolone Sodium Succinate | ANDA | Hikma Pharmaceuticals USA Inc. |
| ANDA212396 | 43598-129 | Methylprednisolone sodium succinate Methylprednisolone sodium succinate | ANDA | Dr. Reddy's Laboratories Inc |
| NDA011856 | 51662-1263 | SOLU-MEDROL SOLU-MEDROL | NDA | HF Acquisition Co. LLC, DBA HealthFirst |
| ANDA207667 | 55150-263 | Methylprednisolone Sodium Succinate Methylprednisolone Sodium Succinate | ANDA | Eugia US LLC |
| ANDA040583 | 63323-258 | Methylprednisolone Sodium Succinate METHYLPREDNISOLONE SODIUM SUCCINATE | ANDA | Fresenius Kabi USA, LLC |
| ANDA207549 | 70121-1001 | Methylprednisolone Sodium Succinate Methylprednisolone | ANDA | Amneal Pharmaceuticals LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | ae524bdb-9fd0-49f9-802d-465a374c175b | 2026-09-08 | Warnings, Adverse reactions | 70518-4345-0 70518-4345 70518434501 70518434500 1743704 |
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | HF Acquisition Co LLC, DBA HealthFirst | 559427ac-9fc6-96f5-e063-6294a90a0b30 | 2026-07-24 | Warnings, Adverse reactions | 51662169503 51662169502 51662169501 1743704 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Sportpharm LLC | 0cb0ba76-067f-46c4-a5d8-b585d5ecafe3 | 2026-07-23 | Warnings, Adverse reactions | 1743704 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 68ef8ec4-16de-4a8c-8696-b09359660380 | 2026-07-17 | Warnings, Adverse reactions | 1743704 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | 7271310c-7764-4812-aa30-a5e90987c7a9 | 2026-06-25 | Warnings, Adverse reactions | 1743704 |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Eugia US LLC | 2035f00e-2299-473a-b004-cb93f541cfa9 | 2026-06-12 | Warnings, Adverse reactions | 55150-263-03 55150-263 55150026303 1743704 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Henry Schein, Inc. | ea2f9b6f-2375-40a6-8b97-b607b9f3ac63 | 2026-06-04 | Warnings, Adverse reactions | 1743704 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | A-S Medication Solutions | 8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9 | 2026-05-29 | Warnings, Adverse reactions | 1743704 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 2af28649-2553-4bcc-9cb1-c73f7cec76d5 | 2026-05-20 | Warnings, Adverse reactions | 1743704 |
| Methylprednisolone sodium succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | f339882f-c380-4022-bdcd-94556a7926aa | 2026-04-15 | Warnings, Adverse reactions | 70518-3684-0 70518-3684 70518368400 70518368401 1743704 |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Civica, Inc. | 2e6020f5-a486-41cc-8956-58b5f6751aa2 | 2026-02-17 | Warnings, Adverse reactions | 72572-098-25 72572-098 72572009801 72572009825 1743704 |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Hikma Pharmaceuticals USA Inc. | 05d95a56-b03a-4d5b-9877-2853ac470fa1 | 2026-02-13 | Warnings, Adverse reactions | 0143-9754-25 0143-9754 00143975401 00143975425 1743704 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 2026-01-30 | Warnings, Adverse reactions | 1743704 |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE | Tianjin Kingyork Pharmaceuticals Co., Ltd | 77a8d96c-37df-4f3a-9757-b2d4131ff82b | 2025-12-18 | Warnings, Adverse reactions | 82094-402-50 82094-402 82094040250 82094040201 1743704 |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE | Amneal Pharmaceuticals LLC | e86fbda8-00e4-4d54-841a-59dea6c15e70 | 2025-12-15 | Warnings, Adverse reactions | 70121-1001-5 70121-1001 70121100105 70121100101 1743704 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | cd99be87-c8d9-48d6-a8e5-e081052e3f19 | 2025-12-02 | Warnings, Adverse reactions | 1743704 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | ProPharma Distribution | 38698075-ac58-b5a4-e063-6294a90a7848 | 2025-07-18 | Warnings, Adverse reactions | 1743704 |
| Methylprednisolone sodium succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Dr. Reddy's Laboratories Inc | 738753c7-507d-4881-5194-02dd7597768b | 2024-06-17 | Warnings, Adverse reactions | 43598-129-25 43598-129 43598012925 43598012901 1743704 |
| SOLU-MEDROL | SOLU-MEDROL | HF Acquisition Co. LLC, DBA HealthFirst | 74e448ed-f4b4-8d09-e053-2991aa0a7500 | 2024-01-29 | Warnings, Adverse reactions | 51662-1263-3 51662-1263 51662126302 51662126303 1743704 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Medical Purchasing Solutions, LLC | 6a26a977-95dd-cdae-e053-2a91aa0a8b0a | 2023-05-30 | Warnings, Adverse reactions | 1743704 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cd99be87-c8d9-48d6-a8e5-e081052e3f19 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 35 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20251202 |
| 8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 33 | SOLU-MEDROL | 20260529 |
| 2af28649-2553-4bcc-9cb1-c73f7cec76d5 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 25 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20260112 |
| e86fbda8-00e4-4d54-841a-59dea6c15e70 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 24 | Methylprednisolone Sodium Succinate for Injection, USP 40 mg/vial (1 mL) and 125 mg/vial (2 mL) Rx only | 20251215 |
| 68ef8ec4-16de-4a8c-8696-b09359660380 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 14 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20251231 |
| 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 12 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20260130 |
| 7271310c-7764-4812-aa30-a5e90987c7a9 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 11 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20251203 |
| ea2f9b6f-2375-40a6-8b97-b607b9f3ac63 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 7 | Solu-Medrol (methylpednisolone sodium succinate for injection, USP) | 20250319 |
| 74e448ed-f4b4-8d09-e053-2991aa0a7500 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 7 | SOLU-MEDROL® 125MG PER VIAL 2mL ACT-O-VIAL® | 20240129 |
| c5d22210-73c6-4697-a267-75e243508642 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 7 | methylPREDNISolone Sodium Succinate for Injection, USP After mixing as directed, contains Benzyl Alcohol. | 20230302 |
| 77a8d96c-37df-4f3a-9757-b2d4131ff82b | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 6 | MethylPREDNISolone Sodium Succinate for Injection, USP | 20251218 |
| f339882f-c380-4022-bdcd-94556a7926aa | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 5 | 20260415 | |
| 05d95a56-b03a-4d5b-9877-2853ac470fa1 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 5 | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | 20260213 |
| 2035f00e-2299-473a-b004-cb93f541cfa9 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 5 | 20240620 | |
| 738753c7-507d-4881-5194-02dd7597768b | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 4 | 20240617 | |
| 6a26a977-95dd-cdae-e053-2a91aa0a8b0a | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 4 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20230530 |
| 2e6020f5-a486-41cc-8956-58b5f6751aa2 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 2 | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | 20260217 |
| 38698075-ac58-b5a4-e063-6294a90a7848 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 2 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20250718 |
| b635e21b-d68d-f60b-e053-2995a90a0f46 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 2 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20230508 |
| 4cc6480c-df7d-0a78-e054-00144ff88e88 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 2 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20170409 |
| ae524bdb-9fd0-49f9-802d-465a374c175b | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 1 | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | 20250527 |
| 22046228-2f23-4990-bb26-9b7eec4d40f8 | methylPREDNISolone sodium succinate 125 MG Injection [PSN] · methylprednisolone 125 MG Injection [SCD] · methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection [SY] | 3 | 1 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20140718 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| ae524bdb-9fd0-49f9-802d-465a374c175b | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | REMEDYREPACK INC. | 20260908 |
| 559427ac-9fc6-96f5-e063-6294a90a0b30 | HF Acquisition Co LLC, DBA HealthFirst | 20260724 | |
| 559427ac-9fc6-96f5-e063-6294a90a0b30 | HF Acquisition Co LLC, DBA HealthFirst | 20260701 | |
| 2035f00e-2299-473a-b004-cb93f541cfa9 | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED | 20260612 | |
| f339882f-c380-4022-bdcd-94556a7926aa | REMEDYREPACK INC. | 20260415 | |
| 2e6020f5-a486-41cc-8956-58b5f6751aa2 | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | 20260217 |
| 05d95a56-b03a-4d5b-9877-2853ac470fa1 | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | Hikma Pharmaceuticals USA Inc. | 20260213 |
| 77a8d96c-37df-4f3a-9757-b2d4131ff82b | MethylPREDNISolone Sodium Succinate for Injection, USP | Tianjin Kingyork Pharmaceuticals Co., Ltd | 20251218 |
| e86fbda8-00e4-4d54-841a-59dea6c15e70 | Methylprednisolone Sodium Succinate for Injection, USP 40 mg/vial (1 mL) and 125 mg/vial (2 mL) Rx only | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | 20251215 |
| 2e6020f5-a486-41cc-8956-58b5f6751aa2 | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | 20250717 |
| ae524bdb-9fd0-49f9-802d-465a374c175b | Methylprednisolone Sodium Succinate for Injection, USP The formulations containing benzyl alcohol should not be used in neonates. For Intravenous or Intramuscular Administration | REMEDYREPACK INC. | 20250527 |
| 2035f00e-2299-473a-b004-cb93f541cfa9 | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED | 20240620 | |
| 738753c7-507d-4881-5194-02dd7597768b | Dr. Reddy's Laboratories Inc | Tianjin Kingyork Pharmaceuticals Co., Ltd | 20240617 | |
| 2a2d6c7a-f7cf-4c88-9512-e762b90199dd | methylPREDNISolone Sodium Succinate for Injection, USP After mixing as directed, contains Benzyl Alcohol. | REMEDYREPACK INC. | 20240312 |
| 74e448ed-f4b4-8d09-e053-2991aa0a7500 | SOLU-MEDROL® 125MG PER VIAL 2mL ACT-O-VIAL® | HF Acquisition Co. LLC, DBA HealthFirst | 20240129 |
| c5d22210-73c6-4697-a267-75e243508642 | methylPREDNISolone Sodium Succinate for Injection, USP After mixing as directed, contains Benzyl Alcohol. | Fresenius Kabi USA, LLC | 20230302 |
| 23b17612-b122-4c89-80a7-5f3ca57fad7f | methylPREDNISolone Sodium Succinate for Injection, USP (Rx only) | GeneYork Pharmaceuticals Group LLC | Tianjin Kingyork Pharmaceuticals Co., Ltd | 20210427 |
| b4e75a4f-e048-4b1d-b9c6-2d79e8b9a6b1 | methylPREDNISolone Sodium Succinate for Injection, USP | REMEDYREPACK INC. | 20201116 |
| cdeae834-fecf-447a-9dd3-616589acd43a | Methylprednisolone Sodium Succinate for Injection, USP | Sagent Pharmaceuticals | 20161024 |
| 1ae6fb26-76b3-40a2-938e-0d2fb48a08f8 | National Council for Prescription Drug Programs | 20130502 | |
| 5689026c-6fa7-45f5-ab08-a9eb9d879c9d | National Council for Prescription Drug Programs | 20130213 | |
| fa08087e-e1f4-4c66-9519-c38a93cf7cae | National Council for Prescription Drug Programs | 20130213 | |
| 5f4e4018-e429-4047-8aeb-fd6997da5062 | National Council for Prescription Drug Programs | 20120724 | |
| 092c7cb9-4b2b-4442-94d9-f54bb84b0bc4 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | methylprednisolone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | methylprednisolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | methylprednisolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | methylprednisolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | D008775 | Methylprednisolone | CHEM | has_ingredient | methylprednisolone |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 125 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA040583 |
| CODES | ANDA | ANDA203125 |
| CODES | ANDA | ANDA207549 |
| CODES | ANDA | ANDA207667 |
| CODES | ANDA | ANDA212396 |
| CODES | NDA | NDA011856 |
| CODES | SNOMEDCT | 1157038004 |
| CODES | VUID | 4003430 |
| NAMES | Prescribable Synonym | methylPREDNISolone sodium succinate 125 MG Injection |
| NAMES | Tallman Synonym | methylPREDNISolone (as methylPREDNISolone sodium succinate) 125 MG Injection |
| NAMES | Tallman Synonym | methylPREDNISolone 125 MG Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |